PRA assessing 'underperforming' JV in light of WuXi going private
Three years on, a joint venture with WuXi Pharmatech is underperforming according to PRA management and could be renegotiated when WuXi goes private.
Archives for November 4, 2015
Indiana aspirin maker hit with Warning due to tablet inconsistencies
Inconsistent tablet colour and issues with compressing procedures have landed Indiana OTC maker American Family Pharmacy (AFP) with a US FDA warning letter.
Almac buys biocatalysis partner Arran, expanding capacity and services
Almac has acquired Arran Chemical Company to further grow its biocatalysis services and increase its large-scale intermediates capacity.
Manganese-based catalyst to offer cost-effective drug properties enhancement
A manganese-based catalyst invented by chemists in Illinois could transform the solubility of drug candidates and improve their therapeutic properties.
Lonza: industry should shift to QC automation
While pharma is increasing use of automation and data integration tools in process development and manufacturing, it lags behind in electronic documentation of quality control, according to Lonza Biologics QC director Jessica Jean.